The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 26 07 2019
accepted: 21 01 2020
entrez: 3 3 2020
pubmed: 3 3 2020
medline: 9 3 2021
Statut: epublish

Résumé

The hinge region of immunoglobulin G (IgG) is involved in C1q and FcγRIIIA-expressing natural killer (NK) cell recruitment. Both heavy chains (HCs) of the hinge region can be cleaved sequentially by several proteases of the tumor/inflammatory/infectious microenvironment, including matrix metalloproteinase 12 (MMP12), or immunoglobulin-degrading enzyme from

Identifiants

pubmed: 32117299
doi: 10.3389/fimmu.2020.00168
pmc: PMC7026020
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antineoplastic Agents, Immunological 0
Bacterial Proteins 0
FCGR3A protein, human 0
FCGR3B protein, human 0
GPI-Linked Proteins 0
Immunoglobulin Fab Fragments 0
Immunoglobulin Fc Fragments 0
Immunoglobulin G 0
Immunoglobulin Joining Region 0
Mac-1-like protein, Streptococcus 0
Receptors, IgG 0
Complement C1q 80295-33-6
MMP12 protein, human EC 3.4.24.65
Matrix Metalloproteinase 12 EC 3.4.24.65

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168

Informations de copyright

Copyright © 2020 Deveuve, Lajoie, Barrault and Thibault.

Références

Int J Cancer. 2013 Aug 1;133(3):757-65
pubmed: 23354868
PLoS One. 2016 Oct 17;11(10):e0164809
pubmed: 27749921
Biochemistry. 2004 Dec 14;43(49):15540-9
pubmed: 15581366
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
Nature. 2000 Jul 20;406(6793):267-73
pubmed: 10917521
Breast Cancer Res. 2018 Jun 1;20(1):43
pubmed: 29859099
J Immunol. 2017 Jan 1;198(1):82-93
pubmed: 27864476
J Biol Chem. 2013 Oct 25;288(43):30843-54
pubmed: 23986451
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3912-3917
pubmed: 29581255
Gastroenterology. 2015 Nov;149(6):1564-1574.e3
pubmed: 26170138
J Immunol Methods. 2004 Nov;294(1-2):15-22
pubmed: 15604012
Mol Immunol. 2011 Jan;48(4):691-6
pubmed: 21168221
Clin Cancer Res. 2015 Dec 1;21(23):5380-90
pubmed: 26224871
Breast Cancer Res. 2012 Aug 08;14(4):R116
pubmed: 22873525
Mol Immunol. 2008 Apr;45(7):1837-46
pubmed: 18157932
Biochem J. 1959 Sep;73:119-26
pubmed: 14434282
MAbs. 2014;6(5):1265-73
pubmed: 25517311
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17864-9
pubmed: 19815504
J Exp Med. 2005 Oct 3;202(7):1001-12
pubmed: 16203869
Science. 1960 Dec 9;132(3441):1770-1
pubmed: 13729245
FEBS Lett. 2013 Jun 19;587(12):1818-22
pubmed: 23665032
Blood. 2012 Jun 14;119(24):5640-9
pubmed: 22535666
Biochem Biophys Res Commun. 2006 Mar 17;341(3):797-803
pubmed: 16442075
Nat Struct Mol Biol. 2015 Dec;22(12):953-8
pubmed: 26595420
J Immunol. 1987 Nov 15;139(10):3536-41
pubmed: 2960735
Blood. 2019 Mar 28;133(13):1395-1405
pubmed: 30655272
Blood. 2015 Jan 29;125(5):762-6
pubmed: 25498911
Clin Exp Immunol. 2013 Jul;173(1):131-9
pubmed: 23607800
Science. 2018 Feb 16;359(6377):794-797
pubmed: 29449492
Immunol Lett. 2002 Apr 1;81(1):41-8
pubmed: 11841844
Analyst. 2013 May 21;138(10):3058-65
pubmed: 23579346
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3485-3490
pubmed: 28289219
MAbs. 2011 Nov-Dec;3(6):558-67
pubmed: 22123056
Nat Biotechnol. 2009 Aug;27(8):767-71
pubmed: 19620983
J Immunol. 2016 Jan 15;196(2):607-13
pubmed: 26685205

Auteurs

Quentin Deveuve (Q)

EA7501 Groupe Innovation et Ciblage Cellulaire, Equipe Fc Récepteurs, Anticorps et MicroEnvironnement, Université de Tours, Tours, France.

Laurie Lajoie (L)

EA7501 Groupe Innovation et Ciblage Cellulaire, Equipe Fc Récepteurs, Anticorps et MicroEnvironnement, Université de Tours, Tours, France.

Benjamin Barrault (B)

EA7501 Groupe Innovation et Ciblage Cellulaire, Equipe Fc Récepteurs, Anticorps et MicroEnvironnement, Université de Tours, Tours, France.

Gilles Thibault (G)

EA7501 Groupe Innovation et Ciblage Cellulaire, Equipe Fc Récepteurs, Anticorps et MicroEnvironnement, Université de Tours, Tours, France.
Laboratoire d'Immunologie, CHRU de Tours, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH